Avalo Therapeutics (AVTX) Institutional Ownership $11.54 -0.10 (-0.86%) (As of 07/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Avalo Therapeutics (NASDAQ:AVTX)CurrentInstitutional OwnershipPercentage87.06%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$30.75MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$45.50K Get AVTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Avalo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AVTX Institutional Buying and Selling by Quarter Ad Monument Traders AllianceThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.See here to see the full details. Avalo Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024Ikarian Capital LLC46,648$1.02M0.1%N/A4.511% 5/15/2024Affinity Asset Advisors LLC10,000$218K0.0%N/A0.971% 5/14/2024Natixis2,512$55K0.0%-45.4%0.244% 11/13/2023Acadian Asset Management LLC283,306$34K0.0%N/A1.399% 8/11/2023VR Adviser LLC1,250,000$444K0.1%+25.0%6.173% 5/16/2023Great Point Partners LLC474,639$831K0.2%N/A3.595% Get the Latest News and Ratings for AVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/5/2023Monashee Investment Management LLC60,000$105K0.0%N/A0.455% 2/15/2023Nantahala Capital Management LLC540,667$2.73M0.2%-1.3%5.746% 11/14/2022Armistice Capital LLC3,964,666$13.16M0.2%-91.7%42.115% 11/14/2022Point72 Asset Management L.P.500,737$1.66M0.0%-91.7%5.319% 11/10/2022Nantahala Capital Management LLC547,814$1.82M0.1%-91.8%5.819% 10/27/2022 Assenagon Asset Management S.A.15,646$52K0.0%N/A0.166% 8/15/2022Nantahala Capital Management LLC6,710,327$3.36M0.2%-2.0%71.280% 8/15/2022Opaleye Management Inc.450,000$225K0.1%-69.1%4.780% 5/12/2022Integral Health Asset Management LLC700,000$507K0.1%-56.9%0.621% 5/3/2022Leo Brokerage LLC62,629$45K0.0%N/A0.056% 4/25/2022 Assenagon Asset Management S.A.42,338$31K0.0%-92.7%0.038% 2/15/2022Stonepine Capital Management LLC1,510,095$2.57M1.2%+77.7%1.344% 2/15/2022LGL Partners LLC28,850$49K0.0%N/A0.026% 2/14/2022Freestone Capital Holdings LLC20,000$34K0.0%N/A0.018% 2/14/2022Soleus Capital Management L.P.770,000$1.31M0.1%N/A0.686% 2/8/2022Northern Trust Corp533,578$907K0.0%+3.1%0.475% 2/1/2022 Assenagon Asset Management S.A.582,718$991K0.0%-33.7%0.519% 1/24/2022Strs Ohio38,400$65K0.0%-40.2%0.034% 1/20/2022Minot Wealth Management LLC34,645$59K0.0%-66.5%0.031% 12/29/2021Hudson Bay Capital Management LP197,133$430K0.0%N/A0.176% 11/16/2021Opaleye Management Inc.1,459,400$3.18M0.6%N/A1.299% 11/16/2021Squarepoint Ops LLC18,657$41K0.0%N/A0.017% 11/16/2021Two Sigma Advisers LP801,300$1.75M0.0%N/A0.713% 11/16/2021Two Sigma Investments LP732,931$1.60M0.0%N/A0.653% 11/16/2021Laurion Capital Management LP330,444$720K0.0%N/A0.294% 11/15/2021Point72 Asset Management L.P.6,008,850$13.10M0.1%N/A5.350% 11/15/2021Atom Investors LP27,507$60K0.0%N/A0.024% 11/15/2021Voya Investment Management LLC21,854$48K0.0%N/A0.019% 11/15/2021 Caas Capital Management LP11,812$26K0.0%N/A0.011% 11/12/2021Aristides Capital LLC48,953$107K0.0%N/A0.044% 11/12/2021Stonepine Capital Management LLC850,000$1.85M0.8%N/A0.770% 11/12/2021Geode Capital Management LLC1,242,382$2.71M0.0%N/A1.126% 11/12/2021Integral Health Asset Management LLC1,625,000$3.54M1.0%N/A1.473% 11/10/2021Goldman Sachs Group Inc.672,664$1.47M0.0%N/A0.610% We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.11/10/2021Creative Planning14,814$32K0.0%N/A0.013% 11/10/2021Alliancebernstein L.P.19,100$42K0.0%N/A0.017% 11/9/2021BlackRock Inc.3,716,943$8.10M0.0%N/A3.369% 11/9/2021Monashee Investment Management LLC270,000$589K0.1%N/A0.245% 11/8/2021Meeder Asset Management Inc.19,260$43K0.0%N/A0.017% 11/4/2021Asymmetry Capital Management L.P.534,621$1.17M0.7%N/A0.485% 11/4/2021Deutsche Bank AG31,794$69K0.0%N/A0.029% 11/2/2021Cambridge Investment Research Advisors Inc.12,164$27K0.0%N/A0.011% 11/2/2021New York State Common Retirement Fund22,214$48K0.0%N/A0.020% 11/2/2021Victory Capital Management Inc.15,788$34K0.0%N/A0.014% 11/1/2021 SG Americas Securities LLC18,596$41K0.0%N/A0.017% 10/29/2021Commonwealth Equity Services LLC52,000$113K0.0%N/A0.047% 10/25/2021Minot Wealth Management LLC103,410$225K0.0%N/A0.094% 10/22/2021Strs Ohio64,200$139K0.0%N/A0.058% 10/19/2021 Assenagon Asset Management S.A.879,334$1.92M0.0%N/A0.797% 10/19/2021Tamar Securities LLC23,084$50K0.0%N/A0.021% (Data available from 1/1/2016 forward) AVTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVTX shares? During the previous two years, 12 institutional investors and hedge funds held shares of Avalo Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($13.16M), Nantahala Capital Management LLC ($2.73M), Point72 Asset Management L.P. ($1.66M), Ikarian Capital LLC ($1.02M), Great Point Partners LLC ($831K), VR Adviser LLC ($444K), and Opaleye Management Inc. ($225K).Learn more on AVTX's institutional investors. What percentage of Avalo Therapeutics stock is owned by institutional investors? 87.06% of Avalo Therapeutics stock is owned by institutional investors. Learn more on AVTX's institutional investor holdings. Which institutional investors have been buying Avalo Therapeutics stock? The following institutional investors have purchased Avalo Therapeutics stock in the last 24 months: Great Point Partners LLC ($474.64K), Acadian Asset Management LLC ($283.31K), VR Adviser LLC ($250K), Monashee Investment Management LLC ($60K), Ikarian Capital LLC ($46.65K), Assenagon Asset Management S.A. ($15.65K), and Affinity Asset Advisors LLC ($10K). How much institutional buying is happening at Avalo Therapeutics? Institutional investors have bought a total of 1,140,239 shares in the last 24 months. This purchase volume represents approximately $267.77M in transactions. Which Avalo Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Avalo Therapeutics stock in the last 24 months: Armistice Capital LLC ($43.61M), Nantahala Capital Management LLC ($6.31M), Point72 Asset Management L.P. ($5.51M), Opaleye Management Inc. ($1.00M), and Natixis ($2.09K). How much institutional selling is happening at Avalo Therapeutics? Institutional investors have sold a total of 56,434,819 shares in the last 24 months. This volume of shares sold represents approximately $45.70B in transactions. Related Companies: Vincerx Pharma Institutional Ownership GlycoMimetics Institutional Ownership Sol-Gel Technologies Institutional Ownership OncoCyte Institutional Ownership Reneo Pharmaceuticals Institutional Ownership BioXcel Therapeutics Institutional Ownership Ocuphire Pharma Institutional Ownership NextCure Institutional Ownership Tempest Therapeutics Institutional Ownership Vaxxinity Institutional Ownership This page (NASDAQ:AVTX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.